ViiV Healthcare UK Ltd

Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Patient Information Leaflet last updated on the eMC: 09/02/2012
PIL Retrovir10 mg/ml IV for Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 09/08/2011 and displayed until 09/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change to Marketing Authorisation Number
Updated on 16/12/2008 and displayed until 09/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 03/06/2008 and displayed until 16/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 26/03/2008 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to date of revision
Updated on 25/08/2005 and displayed until 26/03/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/07/2004 and displayed until 25/08/2005
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/12/2003 and displayed until 12/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 08/05/2002 and displayed until 10/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 22/03/2001 and displayed until 08/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 24/11/2000 and displayed until 22/03/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   zidovudine